Literature DB >> 28287640

Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome.

P Kreetapirom1, S Hongeng1, W Manuyakorn1, U Anurathapan1, S Pakakasama1, N Sirachainan1, B S Andersson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28287640     DOI： 10.1038/bmt.2017.25

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  Hans D Ochs; Adrian J Thrasher
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

2.  Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders.

Authors:  Orly R Klein; Allen R Chen; Christopher Gamper; David Loeb; Elias Zambidis; Nicolas Llosa; Jeffrey Huo; Amy E Dezern; Diana Steppan; Nancy Robey; Mary Jo Holuba; Kenneth R Cooke; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-06       Impact factor: 5.742

3.  Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?

Authors:  Andrew R Gennery; Mary A Slatter; Laure Grandin; Pierre Taupin; Andrew J Cant; Paul Veys; Persis J Amrolia; H Bobby Gaspar; E Graham Davies; Wilhelm Friedrich; Manfred Hoenig; Luigi D Notarangelo; Evelina Mazzolari; Fulvio Porta; Robbert G M Bredius; Arjen C Lankester; Nico M Wulffraat; Reinhard Seger; Tayfun Güngör; Anders Fasth; Petr Sedlacek; Benedicte Neven; Stephane Blanche; Alain Fischer; Marina Cavazzana-Calvo; Paul Landais
Journal:  J Allergy Clin Immunol       Date:  2010-07-31       Impact factor: 10.793

4.  Haploidentical T-cell alpha beta receptor and CD19-depleted stem cell transplant for Wiskott-Aldrich syndrome.

Authors:  Gaurav Kharya; Zohreh Nademi; T Ronan Leahy; Janice Dunn; Dawn Barge; Ansgar Schulz; Andrew Cant; Andrew Gennery; Mary Slatter
Journal:  J Allergy Clin Immunol       Date:  2014-06-27       Impact factor: 10.793

5.  Successful Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in a Severe Combined Immune Deficiency Patient: a First Report.

Authors:  Monia Ouederni; Fethi Mellouli; Monia Ben Khaled; Houda Kaabi; Capucine Picard; Mohamed Bejaoui
Journal:  J Clin Immunol       Date:  2016-05-05       Impact factor: 8.317

6.  Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.

Authors:  U Anurathapan; S Hongeng; S Pakakasama; N Sirachainan; D Songdej; A Chuansumrit; P Charoenkwan; A Jetsrisuparb; K Sanpakit; P Rujkijyanont; A Meekaewkunchorn; Y Lektrakul; P Iamsirirak; P Surapolchai; W Satayasai; S Sirireung; R Sruamsiri; P A Wahidiyat; A Ungkanont; S Issaragrisil; B S Andersson
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.483

7.  Hematopoietic cell transplantation for treatment of primary immune deficiencies.

Authors:  Lauri Burroughs; Ann Woolfrey
Journal:  Cell Ther Transplant       Date:  2010-08-31

Review 8.  Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment.

Authors:  Sung-Yun Pai; Luigi D Notarangelo
Journal:  Immunol Allergy Clin North Am       Date:  2010-05       Impact factor: 3.479

Review 9.  High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Authors:  Leo Luznik; Ephraim J Fuchs
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829
  9 in total
  1 in total

Review 1.  Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders.

Authors:  Tatyana Gavrilova
Journal:  World J Transplant       Date:  2019-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.